» Authors » Ivan G Horvath

Ivan G Horvath

Explore the profile of Ivan G Horvath including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 469
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Onodi Z, Ruppert M, Kucsera D, Sayour A, Toth V, Koncsos G, et al.
Cardiovasc Res . 2021 Jun; 117(13):2639-2651. PMID: 34117866
Aims: Interleukin-1β (IL-1β) is an important pathogenic factor in cardiovascular diseases including chronic heart failure (HF). The CANTOS trial highlighted that inflammasomes as primary sources of IL-1 β are promising...
2.
Brenner G, Giricz Z, Garamvolgyi R, Makkos A, Onodi Z, Sayour N, et al.
J Vis Exp . 2021 May; (170). PMID: 33938885
The development of heart failure is the most powerful predictor of long-term mortality in patients surviving acute myocardial infarction (MI). There is an unmet clinical need for prevention and therapy...
3.
Szapary L, Szakacs Z, Farkas N, Schonfeld K, Babocsay D, Gajer M, et al.
Front Cardiovasc Med . 2021 Feb; 7:608193. PMID: 33585581
The restoration of coronary circulation plays a crucial role in treating ST-segment elevation myocardial infarction (STEMI), however successful reperfusion with primary percutaneous coronary intervention (PPCI) may induce life-threatening arrhythmias. The...
4.
Nemeth B, Peter I, Boncz I, Jagicza A, Kiss I, Csergo A, et al.
Ther Clin Risk Manag . 2019 Jul; 15:831-837. PMID: 31308681
Purpose: Psoriasis is one of the most common lifelong lasting dermatologic diseases. According to the latest studies, psoriatic patients have a higher risk of developing cardiovascular diseases. Psoriasis is considered...
5.
Nemeth B, Kiss I, Ajtay B, Peter I, Kreska Z, Cziraki A, et al.
In Vivo . 2018 Oct; 32(6):1555-1559. PMID: 30348716
Aim: We aimed to investigate the effects of a single carbon dioxide (CO) treatment on arterial stiffness by monitoring the changes of aortic pulse-wave velocity (PWV) and aortic augmentation index...
6.
Tornyos A, Aradi D, Horvath I, Konyi A, Magyari B, Pinter T, et al.
PLoS One . 2017 Dec; 12(12):e0188493. PMID: 29216314
Background: The impact of high platelet reactivity (HPR) on clinical outcomes after elective percutaneous coronary interventions (PCI) with drug-eluting balloons (DEB) due to in-stent restenosis (ISR) is unknown. Objective: We...
7.
Bartunek J, Terzic A, Davison B, Filippatos G, Radovanovic S, Beleslin B, et al.
Eur Heart J . 2016 Dec; 38(9):648-660. PMID: 28025189
Aims: Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy...
8.
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, et al.
EuroIntervention . 2015 Jan; 10(11):1261-6. PMID: 25572023
Aims: To evaluate clinical outcomes in patients receiving the next-generation, paclitaxel-eluting, platinum-chromium TAXUS Element stent in a real-world setting. The PERSEUS Workhorse and Small Vessel studies showed positive results with...
9.
Perjes A, Skoumal R, Tenhunen O, Konyi A, Simon M, Horvath I, et al.
PLoS One . 2014 Apr; 9(4):e93473. PMID: 24695532
Background: Apelin, the endogenous ligand for the G protein-coupled apelin receptor, is an important regulator of the cardiovascular homoeostasis. We previously demonstrated that apelin is one of the most potent...
10.
Aradi D, Tornyos A, Pinter T, Vorobcsuk A, Konyi A, Falukozy J, et al.
J Am Coll Cardiol . 2014 Feb; 63(11):1061-70. PMID: 24486281
Objectives: This study sought to evaluate the impact of treatment with prasugrel and high-dose clopidogrel on the basis of platelet function testing in patients with acute coronary syndrome (ACS) who...